Answers are grounded in this paper and cite their sources.
Mutation prevalence was found to be high among women who were referred for clinical BRCA1 and BRCA2 testing, and the risk was similar across diverse ethnicities. BRCA1 and BRCA2 testing is integral to cancer risk assessment in all high-risk women.
No takes yet. Share an insight, caveat, or question.
Hall et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: